Rexahn Pharmaceuticals Inc., of Rockville, Md., received U.S. Patent No. 8,034,829, titled "5, 6, or 7-Substituted-3-(hetero) arylisoquinolinamine derivatives and therapeutic use therof." It covers several new isoquinolinamine compounds and their pharmaceutical composition and method for producing an antitumor effect.